Jason M. Saltzman
Jason M. Saltzman
Partner at Dentons Canada LLP
(416) 863-4680
77 King St W, Suite 400, Toronto-Dominion Ctr, Toronto, ON
Year called to bar: 2000 (ON); 2000 (New York)
Jason specializes in mergers & acquisitions and corporate and securities transactions. He has expertise in cross-border M&A and private investment in public equity (PIPE) transactions with an emphasis in the life science and mining sectors. He has significant experience in public mergers and acquisitions and other corporate transactions including initial public offerings, public and private offerings of equity and debt, proxy contents and stock exchange listings. Jason is the Vice Chair and Co-Editor of the International Joint Venture Committee Newsletter, ABA, and a Steering Committee Member of the International Private Equity Committee, ABA. He was recognized in the 2022 (and since 2021) edition of The Best Lawyers in Canada (Mergers and Acquisitions Law, Securities Law, Venture Capital Law) and in the 2021 edition (Corporate Law). Jason was also recognized in the 2021 and 2020 editions of IFLR 100: The Guide to the World’s Leading Financial Law Firms as a Rising Star (Capital Markets; M&A).
Jason M. Saltzman is a featured Leading Lawyer in:
Canadian Legal Lexpert Directory
Repeatedly Recommended
Read more about Jason M. Saltzman in ...
On June 13, 2018, CentriLogic, a global provider of managed IT solutions, announced that it secured a significant equity investment from TriSpan Opportunities Fund and Long Point Capital. Financial terms of the investment were not disclosed.
On May 2, 2018, Aurora Cannabis completed its $1.23 billion (US$950 million) takeover bid for all of the outstanding shares CanniMed Therapeutics Inc. This transaction represents the largest to date (completed) acquisition for the Canadian cannabis sector.
On April 3, 2017, Stone Canyon Industries, LLC (SCI) announced the successful closing of its previously announced purchase agreement to acquire Mauser Group N.V. (Mauser), a global supplier of rigid packaging products and services for industrial use, from Clayton, Dubilier & Rice (CD&R), through its subsidiary BWAY Corp. (BWAY), a leading North American manufacturer of rigid metal and plastic containers.
Sunovion Pharmaceuticals Inc. (“Sunovion”) completed the acquisition of Cynapsus Therapeutics Inc. (“Cynapsus”) by way of plan of arrangement for approximately $841 million. The acquisition is aligned with Sunovion’s global strategy to expand and diversify its portfolio in key therapeutic areas, including neurology.
On June 23, 2015, Cynapsus Therapeutics Inc. completed its underwritten public offering in the United States of common shares at US$14.00 per share, for total gross proceeds of approximately US$72.5 million through a syndicate of underwriters led by Bank of America Merrill Lynch that included Nomura and Noble Life Science Partners. The offering was the first ever southbound-only underwritten equity offering under the MJDS and the issuer’s initial public offering in the US.
On June 18, 2015, Energy Fuels. (Energy Fuels) completed the acquisition of Uranerz Energy Corporation (Uranerz) in a merger transaction valued at approximately $135 million. The transaction was a unique and complex cross-border transaction involving the acquisition of a US public corporation (Uranerz) by a Canadian public company (Energy Fuels), with both companies being listed on the TSX and the NYSE MKT stock exchanges.
The Polynt Group, newly acquired CCP Composites, and certain of their subsidiaries (collectively, the Polynt/CCP Group), entered into senior secured US, Canadian, UK and Australian asset-based revolving credit facilities in the aggregate principal amount of US$100 million. The global facility is agented by Wells Fargo Bank, National Association.